-
1
-
-
79952232216
-
Global cancer statistics
-
A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward and D. Forman: Global cancer statistics. CA Cancer J Clin, 61(2), 69-90 (2011).
-
(2011)
CA Cancer J Clin
, vol.61
, Issue.2
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
2
-
-
84855792427
-
Cancer statistics, 2012
-
R. Siegel, D. Naishadham and A. Jemal: Cancer statistics, 2012. CA Cancer J Clin, 62(1), 10-29 (2012).
-
(2012)
CA Cancer J Clin
, vol.62
, Issue.1
, pp. 10-29
-
-
Siegel, R.1
Naishadham, D.2
Jemal, A.3
-
3
-
-
84860721280
-
Germline BRCA1 mutations increase prostate cancer risk
-
D. Leongamornlert, N. Mahmud, M. Tymrakiewicz, E. Saunders, T. Dadaev, E. Castro, C. Goh, K. Govindasami, M. Guy, L. O'Brien, E. Sawyer, A. Hall, R. Wilkinson, D. Easton, D. Goldgar, R. Eeles and Z. Kote-Jarai: Germline BRCA1 mutations increase prostate cancer risk. Br J Cancer, 106(10), 1697-701 (2012).
-
(2012)
Br J Cancer
, vol.106
, Issue.10
, pp. 1697-1701
-
-
Leongamornlert, D.1
Mahmud, N.2
Tymrakiewicz, M.3
Saunders, E.4
Dadaev, T.5
Castro, E.6
Goh, C.7
Govindasami, K.8
Guy, M.9
O'brien, L.10
Sawyer, E.11
Hall, A.12
Wilkinson, R.13
Easton, D.14
Goldgar, D.15
Eeles, R.16
Kote-Jarai, Z.17
-
4
-
-
0037445964
-
Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: A meta-analysis
-
DOI 10.1002/cncr.11262
-
M. P. Zeegers, A. Jellema and H. Ostrer: Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis. Cancer, 97(8), 1894-903 (2003). (Pubitemid 36397263)
-
(2003)
Cancer
, vol.97
, Issue.8
, pp. 1894-1903
-
-
Zeegers, M.P.A.1
Jellema, A.2
Ostrer, H.3
-
5
-
-
73949122747
-
Results from a prostate cancer admixture mapping study in african-american men
-
C. H. Bock, A. G. Schwartz, J. J. Ruterbusch, A. M. Levin, C. Neslund-Dudas, S. J. Land, A. S. Wenzlaff, D. Reich, P. McKeigue, W. Chen, E. I. Heath, I. J. Powell, R. A. Kittles and B. A. Rybicki: Results from a prostate cancer admixture mapping study in African-American men. Hum Genet, 126(5), 637-42 (2009).
-
(2009)
Hum Genet
, vol.126
, Issue.5
, pp. 637-642
-
-
Bock, C.H.1
Schwartz, A.G.2
Ruterbusch, J.J.3
Levin, A.M.4
Neslund-Dudas, C.5
Land, S.J.6
Wenzlaff, A.S.7
Reich, D.8
McKeigue, P.9
Chen, W.10
Heath, E.I.11
Powell, I.J.12
Kittles, R.A.13
Rybicki, B.A.14
-
6
-
-
0038418411
-
Germ-line mutations of the macrophage scavenger receptor 1 gene: Association with prostate cancer risk in African-American men
-
D. C. Miller, S. L. Zheng, R. L. Dunn, A. V. Sarma, J. E. Montie, E. M. Lange, D. A. Meyers, J. Xu and K. A. Cooney: Germ-line mutations of the macrophage scavenger receptor 1 gene: association with prostate cancer risk in African-American men. Cancer Res, 63(13), 3486-9 (2003). (Pubitemid 36793026)
-
(2003)
Cancer Research
, vol.63
, Issue.13
, pp. 3486-3489
-
-
Miller, D.C.1
Zheng, S.L.2
Dunn, R.L.3
Sarma, A.V.4
Montie, J.E.5
Lange, E.M.6
Meyers, D.A.7
Xu, J.8
Cooney, K.A.9
-
7
-
-
84858809529
-
Genetic variants associated with predisposition to prostate cancer and potential clinical implications
-
C. L. Goh, F. R. Schumacher, D. Easton, K. Muir, B. Henderson, Z. Kote-Jarai and R. A. Eeles: Genetic variants associated with predisposition to prostate cancer and potential clinical implications. J Intern Med, 271(4), 353-65 (2012).
-
(2012)
J Intern Med
, vol.271
, Issue.4
, pp. 353-365
-
-
Goh, C.L.1
Schumacher, F.R.2
Easton, D.3
Muir, K.4
Henderson, B.5
Kote-Jarai, Z.6
Eeles, R.A.7
-
9
-
-
1842612064
-
The complex genetic epidemiology of prostate cancer
-
Complex Diseases
-
D. J. Schaid: The complex genetic epidemiology of prostate cancer. Hum Mol Genet, 13 Spec No 1, R103- 21 (2004). (Pubitemid 38443804)
-
(2004)
Human Molecular Genetics
, vol.13
, Issue.1 REV. ISSUE
-
-
Schaid, D.J.1
-
10
-
-
39749129053
-
Multiple newly identified loci associated with prostate cancer susceptibility
-
DOI 10.1038/ng.90, PII NG90
-
R. A. Eeles, Z. Kote-Jarai, G. G. Giles, A. A. Olama, M. Guy, S. K. Jugurnauth, S. Mulholland, D. A. Leongamornlert, S. M. Edwards, J. Morrison, H. I. Field, M. C. Southey, G. Severi, J. L. Donovan, F. C. Hamdy, D. P. Dearnaley, K. R. Muir, C. Smith, M. Bagnato, A. T. Ardern-Jones, A. L. Hall, L. T. O'Brien, B. N. Gehr-Swain, R. A. Wilkinson, A. Cox, S. Lewis, P. M. Brown, S. G. Jhavar, M. Tymrakiewicz, A. Lophatananon, S. L. Bryant, A. Horwich, R. A. Huddart, V. S. Khoo, C. C. Parker, C. J. Woodhouse, A. Thompson, T. Christmas, C. Ogden, C. Fisher, C. Jamieson, C. S. Cooper, D. R. English, J. L. Hopper, D. E. Neal and D. F. Easton: Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet, 40(3), 316-21 (2008). (Pubitemid 351311772)
-
(2008)
Nature Genetics
, vol.40
, Issue.3
, pp. 316-321
-
-
Eeles, R.A.1
Kote-Jarai, Z.2
Giles, G.G.3
Olama, A.A.A.4
Guy, M.5
Jugurnauth, S.K.6
Mulholland, S.7
Leongamornlert, D.A.8
Edwards, S.M.9
Morrison, J.10
Field, H.I.11
Southey, M.C.12
Severi, G.13
Donovan, J.L.14
Hamdy, F.C.15
Dearnaley, D.P.16
Muir, K.R.17
Smith, C.18
Bagnato, M.19
Ardern-Jones, A.T.20
Hall, A.L.21
O'Brien, L.T.22
Gehr-Swain, B.N.23
Wilkinson, R.A.24
Cox, A.25
Lewis, S.26
Brown, P.M.27
Jhavar, S.G.28
Tymrakiewicz, M.29
Lophatananon, A.30
Bryant, S.L.31
Horwich, A.32
Huddart, R.A.33
Khoo, V.S.34
Parker, C.C.35
Woodhouse, C.J.36
Thompson, A.37
Christmas, T.38
Ogden, C.39
Fisher, C.40
Jamieson, C.41
Cooper, C.S.42
English, D.R.43
Hopper, J.L.44
Neal, D.E.45
Easton, D.F.46
more..
-
11
-
-
0016273298
-
Concerning a familial association between breast cancer and both prostatic and uterine malignancies
-
E. U. Thiessen: Concerning a familial association between breast cancer and both prostatic and uterine malignancies. Cancer, 34(4), 1102-7 (1974).
-
(1974)
Cancer
, vol.34
, Issue.4
, pp. 1102-1107
-
-
Thiessen, E.U.1
-
12
-
-
0026657958
-
Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer
-
H. Tulinius, V. Egilsson, G. H. Olafsdottir and H. Sigvaldason: Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer. BMJ, 305(6858), 855-7 (1992).
-
(1992)
BMJ
, vol.305
, Issue.6858
, pp. 855-857
-
-
Tulinius, H.1
Egilsson, V.2
Olafsdottir, G.H.3
Sigvaldason, H.4
-
13
-
-
0027258542
-
Familial breast cancer risks: Effects of prostate and other cancers
-
D. E. Anderson and M. D. Badzioch: Familial breast cancer risks. Effects of prostate and other cancers. Cancer, 72(1), 114-9 (1993). (Pubitemid 23182059)
-
(1993)
Cancer
, vol.72
, Issue.1
, pp. 114-119
-
-
Anderson, D.E.1
Badzioch, M.D.2
-
14
-
-
0028555342
-
Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer
-
T. A. Sellers, J. D. Potter, S. S. Rich, C. R. Drinkard, R. M. Bostick, L. H. Kushi, W. Zheng and A. R. Folsom: Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer. J Natl Cancer Inst, 86(24), 1860-5 (1994).
-
(1994)
J Natl Cancer Inst
, vol.86
, Issue.24
, pp. 1860-1865
-
-
Sellers, T.A.1
Potter, J.D.2
Rich, S.S.3
Drinkard, C.R.4
Bostick, R.M.5
Kushi, L.H.6
Zheng, W.7
Folsom, A.R.8
-
15
-
-
0027494344
-
Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic cancer
-
A. Arason, R. B. Barkardottir and V. Egilsson: Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic cancer. Am J Hum Genet, 52(4), 711-7 (1993). (Pubitemid 23310137)
-
(1993)
American Journal of Human Genetics
, vol.52
, Issue.4
, pp. 711-717
-
-
Arason, A.1
Barkardottir, R.B.2
Egilsson, V.3
-
16
-
-
0028113345
-
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
-
Y. Miki, J. Swensen, D. Shattuck-Eidens, P. A. Futreal, K. Harshman, S. Tavtigian, Q. Liu, C. Cochran, L. M. Bennett, W. Ding and et al.: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266(5182), 66-71 (1994). (Pubitemid 24345325)
-
(1994)
Science
, vol.266
, Issue.5182
, pp. 66-71
-
-
Miki, Y.1
Swensen, J.2
Shattuck-Eidens, D.3
Futreal, P.A.4
Harshman, K.5
Tavtigian, S.6
Liu, Q.7
Cochran, C.8
Bennett, L.M.9
Ding, W.10
Bell, R.11
Rosenthal, J.12
Hussey, C.13
Tran, T.14
McClure, M.15
Frye, C.16
Hattier, T.17
Phelps, R.18
Haugen-Strano, A.19
Katcher, H.20
Yakumo, K.21
Gholami, Z.22
Shaffer, D.23
Stone, S.24
Bayer, S.25
Wray, C.26
Bogden, R.27
Dayananth, P.28
Ward, J.29
Tonin, P.30
Narod, S.31
Bristow, P.K.32
Norris, F.H.33
Helvering, L.34
Morrison, P.35
Rosteck, P.36
Lai, M.37
Barrett, J.C.38
Lewis, C.39
Neuhausen, S.40
Cannon-Albright, L.41
Goldgar, D.42
Wiseman, R.43
Kamb, A.44
Skolnick, M.H.45
more..
-
17
-
-
0027433563
-
Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families
-
D. F. Easton, D. T. Bishop, D. Ford and G. P. Crockford: Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet, 52(4), 678- 701 (1993). (Pubitemid 23310135)
-
(1993)
American Journal of Human Genetics
, vol.52
, Issue.4
, pp. 678-701
-
-
Easton, D.F.1
Bishop, D.T.2
Ford, D.3
Crockford, G.P.4
Haites, N.5
Milner, B.6
Allan, L.7
King, M.-C.8
Bowcock, A.9
Anderson, L.10
Easton, D.F.11
Ponder, B.A.J.12
Peto, J.13
Smith, S.14
Anderson, K.15
Ford, D.16
Stratton, M.17
Sobol, H.18
Mazoyer, S.19
-
18
-
-
0025613812
-
Linkage of early-onset familial breast cancer to chromosome 17q21
-
J. M. Hall, M. K. Lee, B. Newman, J. E. Morrow, L. A. Anderson, B. Huey and M. C. King: Linkage of early-onset familial breast cancer to chromosome 17q21. Science, 250(4988), 1684-9 (1990). (Pubitemid 120031871)
-
(1990)
Science
, vol.250
, Issue.4988
, pp. 1684-1689
-
-
Hall, J.M.1
Lee, M.K.2
Newman, B.3
Morrow, J.E.4
Anderson, L.A.5
Huey, B.6
King, M.-C.7
-
19
-
-
0031821621
-
Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancer
-
DOI 10.1002/(SICI)1097-0215(19980925)78:1 <1::AID-IJC1 >3.0.CO;2-U
-
S. M. Edwards, W. D. Dunsmuir, C. E. Gillett, S. R. Lakhani, C. Corbishley, M. Young, R. S. Kirby, D. P. Dearnaley, A. Dowe, A. Ardern-Jones, J. Kelly, N. Spurr, D. M. Barnes and R. A. Eeles: Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancer. CRC/BPG UK Familial Prostate Cancer Study Collaborators. Int J Cancer, 78(1), 1-7 (1998). (Pubitemid 28391665)
-
(1998)
International Journal of Cancer
, vol.78
, Issue.1
, pp. 1-7
-
-
Edwards, S.M.1
Dunsmuir, W.D.2
Gillett, C.E.3
Lakhani, S.R.4
Corbishley, C.5
Young, M.6
Kirby, R.S.7
Dearnaley, D.P.8
Dowe, A.9
Ardern-Jones, A.10
Kelly, J.O.11
Spurr, N.12
Barnes, D.M.13
Eeles, R.A.14
-
20
-
-
0028006563
-
Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13
-
R. Wooster, S. L. Neuhausen, J. Mangion, Y. Quirk, D. Ford, N. Collins, K. Nguyen, S. Seal, T. Tran, D. Averill and et al.: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science, 265(5181), 2088-90 (1994). (Pubitemid 24325690)
-
(1994)
Science
, vol.265
, Issue.5181
, pp. 2088-2090
-
-
Wooster, R.1
Neuhausen, S.L.2
Mangion, J.3
Quirk, Y.4
Ford, D.5
Collins, N.6
Nguyen, K.7
Seal, S.8
Tran, T.9
Averill, D.10
Fields, P.11
Marshall, G.12
Narod, S.13
Lenoir, G.M.14
Lynch, H.15
Feunteun, J.16
Devilee, P.17
Cornelisse, C.J.18
Menko, F.H.19
Daly, P.A.20
Ormiston, W.21
McManus, R.22
Pye, C.23
Lewis, C.M.24
Cannon-Albright, L.A.25
Peto, J.26
Ponder, B.A.J.27
Skolnick, M.H.28
Easton, D.F.29
Goldgar, D.E.30
Stratton, M.R.31
more..
-
21
-
-
0038743059
-
Regulation of BRCA1 expression and its relationship to sporadic breast cancer
-
DOI 10.1186/bcr557
-
C. R. Mueller and C. D. Roskelley: Regulation of BRCA1 expression and its relationship to sporadic breast cancer. Breast Cancer Res, 5(1), 45-52 (2003). (Pubitemid 36553579)
-
(2003)
Breast Cancer Research
, vol.5
, Issue.1
, pp. 45-52
-
-
Mueller, C.R.1
Roskelley, C.D.2
-
22
-
-
84865182680
-
A diagnostic genetic test for the physical mapping of germline rearrangements in the susceptibility breast cancer genes brca1 and brca2
-
K. Cheeseman, E. Rouleau, A. Vannier, A. Thomas, A. Briaux, C. Lefol, P. Walrafen, A. Bensimon, R. Lidereau, E. Conseiller and M. Ceppi: A diagnostic genetic test for the physical mapping of germline rearrangements in the susceptibility breast cancer genes BRCA1 and BRCA2. Hum Mutat, 33(6), 998-1009 (2012).
-
(2012)
Hum Mutat
, vol.33
, Issue.6
, pp. 998-1009
-
-
Cheeseman, K.1
Rouleau, E.2
Vannier, A.3
Thomas, A.4
Briaux, A.5
Lefol, C.6
Walrafen, P.7
Bensimon, A.8
Lidereau, R.9
Conseiller, E.10
Ceppi, M.11
-
23
-
-
77951069726
-
Immunohistochemical expression of BRCA1 and lethal prostate cancer
-
M. Fiorentino, G. Judson, K. Penney, R. Flavin, J. Stark, C. Fiore, K. Fall, N. Martin, J. Ma, J. Sinnott, E. Giovannucci, M. Stampfer, H. D. Sesso, P. W. Kantoff, S. Finn, M. Loda and L. Mucci: Immunohistochemical expression of BRCA1 and lethal prostate cancer. Cancer Res, 70(8), 3136-9 (2010).
-
(2010)
Cancer Res
, vol.70
, Issue.8
, pp. 3136-3139
-
-
Fiorentino, M.1
Judson, G.2
Penney, K.3
Flavin, R.4
Stark, J.5
Fiore, C.6
Fall, K.7
Martin, N.8
Ma, J.9
Sinnott, J.10
Giovannucci, E.11
Stampfer, M.12
Sesso, H.D.13
Kantoff, P.W.14
Finn, S.15
Loda, M.16
Mucci, L.17
-
24
-
-
2642611983
-
Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers
-
DOI 10.1002/(SICI)1097-0215(19980703)77:1<1::AID-IJC1>3.0.CO;2-Y
-
H. Ozcelik, M. D. To, J. Couture, S. B. Bull and I. L. Andrulis: Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers. Int J Cancer, 77(1), 1-6 (1998). (Pubitemid 28308543)
-
(1998)
International Journal of Cancer
, vol.77
, Issue.1
, pp. 1-6
-
-
Ozcelik, H.1
To, M.D.T.2
Couture, J.3
Bull, S.B.4
Andrulis, I.L.5
-
25
-
-
0029894211
-
Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer
-
M. W. Beckmann, F. Picard, H. X. An, C. R. van Roeyen, S. I. Dominik, D. S. Mosny, H. G. Schnurch, H. G. Bender and D. Niederacher: Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. Br J Cancer, 73(10), 1220-6 (1996). (Pubitemid 26162336)
-
(1996)
British Journal of Cancer
, vol.73
, Issue.10
, pp. 1220-1226
-
-
Beckmann, M.W.1
Picard, F.2
An, H.X.3
Van Roeyen, C.4
Dominik, S.I.5
Mosny, D.S.6
Schnurch, H.G.7
Bender, H.G.8
Niederacher, D.9
-
26
-
-
0032542339
-
Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region
-
F. Magdinier, S. Ribieras, G. M. Lenoir, L. Frappart and R. Dante: Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region. Oncogene, 17(24), 3169-76 (1998). (Pubitemid 29020812)
-
(1998)
Oncogene
, vol.17
, Issue.24
, pp. 3169-3176
-
-
Magdinier, F.1
Ribieras, S.2
Lenoir, G.M.3
Frappart, L.4
Dante, R.5
-
27
-
-
0033580432
-
Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: Correlation with disease characteristics
-
A. Catteau, W. H. Harris, C. F. Xu and E. Solomon: Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene, 18(11), 1957-65 (1999). (Pubitemid 29150082)
-
(1999)
Oncogene
, vol.18
, Issue.11
, pp. 1957-1965
-
-
Catteau, A.1
Harris, W.H.2
Xu, C.-F.3
Solomon, E.4
-
29
-
-
0028330276
-
Risks of cancer in BRCA1-mutation carriers
-
DOI 10.1016/S0140-6736(94)91578-4
-
D. Ford, D. F. Easton, D. T. Bishop, S. A. Narod and D. E. Goldgar: Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet, 343(8899), 692-5 (1994). (Pubitemid 24087847)
-
(1994)
Lancet
, vol.343
, Issue.8899
, pp. 692-695
-
-
Ford, D.1
Easton, D.F.2
Bishop, D.T.3
Narod, S.A.4
Goldgar, D.E.5
-
30
-
-
0037222306
-
Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene
-
DOI 10.1086/345310
-
S. M. Edwards, Z. Kote-Jarai, J. Meitz, R. Hamoudi, Q. Hope, P. Osin, R. Jackson, C. Southgate, R. Singh, A. Falconer, D. P. Dearnaley, A. Ardern-Jones, A. Murkin, A. Dowe, J. Kelly, S. Williams, R. Oram, M. Stevens, D. M. Teare, B. A. Ponder, S. A. Gayther, D. F. Easton and R. A. Eeles: Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet, 72(1), 1-12 (2003). (Pubitemid 36056838)
-
(2003)
American Journal of Human Genetics
, vol.72
, Issue.1
, pp. 1-12
-
-
Edwards, S.M.1
Kote-Jarai, Z.2
Meitz, J.3
Hamoudi, R.4
Hope, Q.5
Osin, P.6
Jackson, R.7
Southgate, C.8
Singh, R.9
Falconer, A.10
Dearnaley, D.P.11
Ardern-Jones, A.12
Murkin, A.13
Dowe, A.14
Kelly, J.15
Williams, S.16
Oram, R.17
Stevens, M.18
Teare, D.M.19
Ponder, B.A.J.20
Gayther, S.A.21
Easton, D.F.22
Eeles, R.A.23
more..
-
31
-
-
0035125062
-
Variation in cancer risks, by mutation position, in BRCA2 mutation carriers
-
DOI 10.1086/318181
-
D. Thompson and D. Easton: Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet, 68(2), 410-9 (2001). (Pubitemid 32147810)
-
(2001)
American Journal of Human Genetics
, vol.68
, Issue.2
, pp. 410-419
-
-
Thompson, D.1
Easton, D.2
-
32
-
-
0033523268
-
Cancer risks in BRCA2 mutation carriers. The breast cancer linkage consortium
-
Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J Natl Cancer Inst, 91(15), 1310-6 (1999).
-
(1999)
J Natl Cancer Inst
, vol.91
, Issue.15
, pp. 1310-1316
-
-
-
33
-
-
16944365740
-
Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13
-
D. F. Easton, L. Steele, P. Fields, W. Ormiston, D. Averill, P. A. Daly, R. McManus, S. L. Neuhausen, D. Ford, R. Wooster, L. A. Cannon-Albright, M. R. Stratton and D. E. Goldgar: Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet, 61(1), 120-8 (1997). (Pubitemid 27323331)
-
(1997)
American Journal of Human Genetics
, vol.61
, Issue.1
, pp. 120-128
-
-
Easton, D.F.1
Steele, L.2
Fields, P.3
Ormiston, W.4
Averill, D.5
Daly, P.A.6
McManus, R.7
Neuhausen, S.L.8
Ford, D.9
Wooster, R.10
Cannon-Albright, L.A.11
Stratton, M.R.12
Goldgar, D.E.13
-
34
-
-
78650657873
-
Targeted prostate cancer screening in men with mutations in brca1 and brca2 detects aggressive prostate cancer: Preliminary analysis of the results of the impact study
-
A. V. Mitra, E. K. Bancroft, Y. Barbachano, E. C. Page, C. S. Foster, C. Jameson, G. Mitchell, G. J. Lindeman, A. Stapleton, G. Suthers, D. G. Evans, D. Cruger, I. Blanco, C. Mercer, J. Kirk, L. Maehle, S. Hodgson, L. Walker, L. Izatt, F. Douglas, K. Tucker, H. Dorkins, V. Clowes, A. Male, A. Donaldson, C. Brewer, R. Doherty, B. Bulman, P. J. Osther, M. Salinas, D. Eccles, K. Axcrona, I. Jobson, B. Newcombe, C. Cybulski, W. S. Rubinstein, S. Buys, S. Townshend, E. Friedman, S. Domchek, Y. C. T. Ramon, A. Spigelman, S. H. Teo, N. Nicolai, N. Aaronson, A. Ardern-Jones, C. Bangma, D. Dearnaley, J. Eyfjord, A. Falconer, H. Gronberg, F. Hamdy, O. Johannsson, V. Khoo, Z. Kote-Jarai, H. Lilja, J. Lubinski, J. Melia, C. Moynihan, S. Peock, G. Rennert, F. Schroder, P. Sibley, M. Suri, P. Wilson, Y. J. Bignon, S. Strom, M. Tischkowitz, A. Liljegren, D. Ilencikova, A. Abele, K. Kyriacou, C. van Asperen, L. Kiemeney, D. F. Easton and R. A. Eeles: Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int, 107(1), 28-39 (2011).
-
(2011)
BJU Int
, vol.107
, Issue.1
, pp. 28-39
-
-
Mitra, A.V.1
Bancroft, E.K.2
Barbachano, Y.3
Page, E.C.4
Foster, C.S.5
Jameson, C.6
Mitchell, G.7
Lindeman, G.J.8
Stapleton, A.9
Suthers, G.10
Evans, D.G.11
Cruger, D.12
Blanco, I.13
Mercer, C.14
Kirk, J.15
Maehle, L.16
Hodgson, S.17
Walker, L.18
Izatt, L.19
Douglas, F.20
Tucker, K.21
Dorkins, H.22
Clowes, V.23
Male, A.24
Donaldson, A.25
Brewer, C.26
Doherty, R.27
Bulman, B.28
Osther, P.J.29
Salinas, M.30
Eccles, D.31
Axcrona, K.32
Jobson, I.33
Newcombe, B.34
Cybulski, C.35
Rubinstein, W.S.36
Buys, S.37
Townshend, S.38
Friedman, E.39
Domchek, S.40
Ramon, Y.C.T.41
Spigelman, A.42
Teo, S.H.43
Nicolai, N.44
Aaronson, N.45
Ardern-Jones, A.46
Bangma, C.47
Dearnaley, D.48
Eyfjord, J.49
Falconer, A.50
Gronberg, H.51
Hamdy, F.52
Johannsson, O.53
Khoo, V.54
Kote-Jarai, Z.55
Lilja, H.56
Lubinski, J.57
Melia, J.58
Moynihan, C.59
Peock, S.60
Rennert, G.61
Schroder, F.62
Sibley, P.63
Suri, M.64
Wilson, P.65
Bignon, Y.J.66
Strom, S.67
Tischkowitz, M.68
Liljegren, A.69
Ilencikova, D.70
Abele, A.71
Kyriacou, K.72
Van Asperen, C.73
Kiemeney, L.74
Easton, D.F.75
Eeles, R.A.76
more..
-
35
-
-
77954162660
-
Brca2 and trp53 deficiency cooperate in the progression of mouse prostate tumourigenesis
-
J. C. Francis, A. McCarthy, M. K. Thomsen, A. Ashworth and A. Swain: Brca2 and Trp53 deficiency cooperate in the progression of mouse prostate tumourigenesis. PLoS Genet, 6(6), e1000995 (2010).
-
(2010)
PLoS Genet
, vol.6
, Issue.6
-
-
Francis, J.C.1
McCarthy, A.2
Thomsen, M.K.3
Ashworth, A.4
Swain, A.5
-
36
-
-
80051975216
-
BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer
-
P. De Luca, E. S. Vazquez, C. P. Moiola, F. Zalazar, J. Cotignola, G. Gueron, K. Gardner and A. De Siervi: BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer. Mol Cancer Res, 9(8), 1078- 90 (2011).
-
(2011)
Mol Cancer Res
, vol.9
, Issue.8
, pp. 1078-1090
-
-
De Luca, P.1
Vazquez, E.S.2
Moiola, C.P.3
Zalazar, F.4
Cotignola, J.5
Gueron, G.6
Gardner, K.7
De Siervi, A.8
-
37
-
-
0029050356
-
BRCA1 mutations in ashkenazi jewish women
-
P. Tonin, O. Serova, G. Lenoir, H. Lynch, F. Durocher, J. Simard, K. Morgan and S. Narod: BRCA1 mutations in Ashkenazi Jewish women. Am J Hum Genet, 57(1), 189 (1995).
-
(1995)
Am J Hum Genet
, vol.57
, Issue.1
, pp. 189
-
-
Tonin, P.1
Serova, O.2
Lenoir, G.3
Lynch, H.4
Durocher, F.5
Simard, J.6
Morgan, K.7
Narod, S.8
-
38
-
-
4544374528
-
BRCA1 and BRCA2: 1994 and beyond
-
DOI 10.1038/nrc1431
-
S. A. Narod and W. D. Foulkes: BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer, 4(9), 665-76 (2004). (Pubitemid 39215065)
-
(2004)
Nature Reviews Cancer
, vol.4
, Issue.9
, pp. 665-676
-
-
Narod, S.A.1
Foulkes, W.D.2
-
39
-
-
0027939506
-
Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families
-
DOI 10.1038/ng1294-392
-
J. Simard, P. Tonin, F. Durocher, K. Morgan, J. Rommens, S. Gingras, C. Samson, J. F. Leblanc, C. Belanger, F. Dion and et al.: Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet, 8(4), 392-8 (1994). (Pubitemid 24375607)
-
(1994)
Nature Genetics
, vol.8
, Issue.4
, pp. 392-398
-
-
Simard, J.1
Tonin, P.2
Durocher, F.3
Morgan, K.4
Rommens, J.5
Gingras, S.6
Samson, C.7
Leblanc, J.-F.8
Belanger, C.9
Dion, F.10
Liu, Q.11
Skolnick, M.12
Goldgar, D.13
Shattuck-Eidens, D.14
Labrie, F.15
Narod, S.A.16
-
41
-
-
19144362921
-
Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: Results of an international study
-
S. L. Neuhausen, S. Mazoyer, L. Friedman, M. Stratton, K. Offit, A. Caligo, G. Tomlinson, L. Cannon-Albright, T. Bishop, D. Kelsell, E. Solomon, B. Weber, F. Couch, J. Struewing, P. Tonin, F. Durocher, S. Narod, M. H. Skolnick, G. Lenoir, O. Serova, B. Ponder, D. Stoppa- Lyonnet, D. Easton, M. C. King and D. E. Goldgar: Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet, 58(2), 271-80 (1996). (Pubitemid 26038932)
-
(1996)
American Journal of Human Genetics
, vol.58
, Issue.2
, pp. 271-280
-
-
Neuhausen, S.L.1
Mazoyer, S.2
Friedman, L.3
Stratton, M.4
Offit, K.5
Caligo, A.6
Tomlinson, G.7
Cannon-Albright, L.8
Bishop, T.9
Kelsell, D.10
Solomon, E.11
Weber, B.12
Couch, F.13
Struewing, J.14
Tonin, P.15
Durocher, F.16
Narod, S.17
Skolnick, M.H.18
Lenoir, G.19
Serova, O.20
Ponder, B.21
Stoppa-Lyonnet, D.22
Easton, D.23
King, M.-C.24
Goldgar, D.E.25
more..
-
42
-
-
36448996703
-
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations
-
DOI 10.1038/nrc2054, PII NRC2054
-
J. D. Fackenthal and O. I. Olopade: Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer, 7(12), 937-48 (2007). (Pubitemid 350165853)
-
(2007)
Nature Reviews Cancer
, vol.7
, Issue.12
, pp. 937-948
-
-
Fackenthal, J.D.1
Olopade, O.I.2
-
43
-
-
2442440933
-
BRCA mutations and risk of prostate cancer in ashkenazi jews
-
DOI 10.1158/1078-0432.CCR-03-0604
-
T. Kirchhoff, N. D. Kauff, N. Mitra, K. Nafa, H. Huang, C. Palmer, T. Gulati, E. Wadsworth, S. Donat, M. E. Robson, N. A. Ellis and K. Offit: BRCA mutations and risk of prostate cancer in Ashkenazi Jews. Clin Cancer Res, 10(9), 2918-21 (2004). (Pubitemid 38619665)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.9
, pp. 2918-2921
-
-
Kirchhoff, T.1
Kauff, N.D.2
Mitra, N.3
Nafa, K.4
Huang, H.5
Palmer, C.6
Gulati, T.7
Wadsworth, E.8
Donat, S.9
Robson, M.E.10
Ellis, N.A.11
Offit, K.12
-
44
-
-
0033358578
-
The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer [4]
-
DOI 10.1086/302525
-
A. Hubert, T. Peretz, O. Manor, L. Kaduri, N. Wienberg, I. Lerer, M. Sagi and D. Abeliovich: The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer. Am J Hum Genet, 65(3), 921- 4 (1999). (Pubitemid 30468737)
-
(1999)
American Journal of Human Genetics
, vol.65
, Issue.3
, pp. 921-924
-
-
Hubert, A.1
Peretz, T.2
Manor, O.3
Kaduri, L.4
Wienberg, N.5
Lerer, I.6
Sagi, M.7
Abeliovich, D.8
-
45
-
-
61349148781
-
Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations
-
I. Agalliu, R. Gern, S. Leanza and R. D. Burk: Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations. Clin Cancer Res, 15(3), 1112-20 (2009).
-
(2009)
Clin Cancer Res
, vol.15
, Issue.3
, pp. 1112-1120
-
-
Agalliu, I.1
Gern, R.2
Leanza, S.3
Burk, R.D.4
-
46
-
-
0031711516
-
Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer
-
S. Lehrer, F. Fodor, R. G. Stock, N. N. Stone, C. Eng, H. K. Song and M. McGovern: Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer. Br J Cancer, 78(6), 771-3 (1998). (Pubitemid 28418311)
-
(1998)
British Journal of Cancer
, vol.78
, Issue.6
, pp. 771-773
-
-
Lehrer, S.1
Fodor, F.2
Stock, R.G.3
Stone, N.N.4
Eng, C.5
Song, H.K.6
McGovern, M.7
-
47
-
-
0032764893
-
Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men
-
DOI 10.1002/(SICI)1097-0045(19990801)40:3 <172::AID-PROS5 >3.0.CO;2-R
-
K. L. Nastiuk, M. Mansukhani, M. B. Terry, P. Kularatne, M. A. Rubin, J. Melamed, M. D. Gammon, M. Ittmann and J. J. Krolewski: Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men. Prostate, 40(3), 172-7 (1999). (Pubitemid 29334865)
-
(1999)
Prostate
, vol.40
, Issue.3
, pp. 172-177
-
-
Nastiuk, K.L.1
Mansukhani, M.2
Terry, M.B.3
Kularatne, P.4
Rubin, M.A.5
Melamed, J.6
Gammon, M.D.7
Ittmann, M.8
Krolewski, J.J.9
-
48
-
-
0033152476
-
No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer
-
DOI 10.1002/(SICI)1097-0045(19990601)39:4<280::AID-PROS8>3.0.CO;2-F
-
E. P. Wilkens, D. Freije, J. Xu, D. R. Nusskern, H. Suzuki, S. D. Isaacs, K. Wiley, P. Bujnovsky, D. A. Meyers, P. C. Walsh and W. B. Isaacs: No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer. Prostate, 39(4), 280-4 (1999). (Pubitemid 29244502)
-
(1999)
Prostate
, vol.39
, Issue.4
, pp. 280-284
-
-
Wilkens, E.P.1
Freije, D.2
Xu, J.3
Nusskern, D.R.4
Suzuki, H.5
Isaacs, S.D.6
Wiley, K.7
Bujnovszky, P.8
Meyers, D.A.9
Walsh, P.C.10
Isaacs, W.B.11
-
49
-
-
0033943282
-
The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel
-
A. Vazina, J. Baniel, Y. Yaacobi, A. Shtriker, D. Engelstein, I. Leibovitz, M. Zehavi, A. A. Sidi, Y. Ramon, T. Tischler, P. M. Livne and E. Friedman: The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel. Br J Cancer, 83(4), 463-6 (2000). (Pubitemid 30487858)
-
(2000)
British Journal of Cancer
, vol.83
, Issue.4
, pp. 463-466
-
-
Vazina, A.1
Baniel, J.2
Yaacobi, Y.3
Shtriker, A.4
Engelstein, D.5
Leibovitz, I.6
Zehavi, M.7
Sidi, A.A.8
Ramon, Y.9
Tischler, T.10
Livne, P.M.11
Friedman, E.12
-
50
-
-
0142209176
-
A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology
-
R. M. Giusti, J. L. Rutter, P. H. Duray, L. S. Freedman, M. Konichezky, J. Fisher-Fischbein, M. H. Greene, B. Maslansky, A. Fischbein, S. B. Gruber, G. Rennert, R. D. Ronchetti, S. M. Hewitt, J. P. Struewing and J. Iscovich: A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology. J Med Genet, 40(10), 787-92 (2003). (Pubitemid 37311080)
-
(2003)
Journal of Medical Genetics
, vol.40
, Issue.10
, pp. 787-792
-
-
Giusti, R.M.1
Rutter, J.L.2
Duray, P.H.3
Freedman, L.S.4
Konichezky, M.5
Fisher-Fischbein, J.6
Greene, M.H.7
Maslansky, B.8
Fischbein, A.9
Gruber, S.B.10
Rennert, G.11
Ronchetti, R.D.12
Hewitt, S.M.13
Struewing, J.P.14
Iscovich, J.15
-
51
-
-
80054087237
-
BRCA1 mutations do not increase prostate cancer risk: Results from a meta-analysis including new data
-
L. Fachal, A. Gomez-Caamano, C. Celeiro-Munoz, P. Peleteiro, A. Blanco, A. Carballo, J. Forteza, A. Carracedo and A. Vega: BRCA1 mutations do not increase prostate cancer risk: results from a meta-analysis including new data. Prostate, 71(16), 1768-79 (2011).
-
(2011)
Prostate
, vol.71
, Issue.16
, pp. 1768-1779
-
-
Fachal, L.1
Gomez-Caamano, A.2
Celeiro-Munoz, C.3
Peleteiro, P.4
Blanco, A.5
Carballo, A.6
Forteza, J.7
Carracedo, A.8
Vega, A.9
-
52
-
-
0030140026
-
A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes
-
S. Thorlacius, G. Olafsdottir, L. Tryggvadottir, S. Neuhausen, J. G. Jonasson, S. V. Tavtigian, H. Tulinius, H. M. Ogmundsdottir and J. E. Eyfjord: A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet, 13(1), 117-9 (1996). (Pubitemid 126528241)
-
(1996)
Nature Genetics
, vol.13
, Issue.1
, pp. 117-119
-
-
Thorlacius, S.1
Olafsdottir, G.2
Tryggvadottir, L.3
Neuhausen, S.4
Jonasson, J.G.5
Tavtigian, S.V.6
Tulinius, H.7
Ogmundsdottir, H.M.8
Eyfjord, J.E.9
-
53
-
-
9444248601
-
High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients
-
G. Johannesdottir, J. Gudmundsson, J. T. Bergthorsson, A. Arason, B. A. Agnarsson, G. Eiriksdottir, O. T. Johannsson, A. Borg, S. Ingvarsson, D. F. Easton, V. Egilsson and R. B. Barkardottir: High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients. Cancer Res, 56(16), 3663-5 (1996). (Pubitemid 26272009)
-
(1996)
Cancer Research
, vol.56
, Issue.16
, pp. 3663-3665
-
-
Johannesdottir, G.1
Gudmundsson, J.2
Bergthorsson, J.T.3
Arason, A.4
Agnarsson, B.A.5
Eiriksdottir, G.6
Johannsson, O.T.7
Borg, A.8
Ingvarsson, S.9
Easton, D.F.10
Egilsson, V.11
Barkardottir, R.B.12
-
54
-
-
0030870451
-
BRCA2 mutation in Icelandic prostate cancer patients
-
DOI 10.1007/s001090050162
-
S. Sigurdsson, S. Thorlacius, J. Tomasson, L. Tryggvadottir, K. Benediktsdottir, J. E. Eyfjord and E. Jonsson: BRCA2 mutation in Icelandic prostate cancer patients. J Mol Med (Berl), 75(10), 758-61 (1997). (Pubitemid 27451978)
-
(1997)
Journal of Molecular Medicine
, vol.75
, Issue.10
, pp. 758-761
-
-
Sigurdsson, S.1
Thorlacius, S.2
Tomasson, J.3
Tryggvadottir, L.4
Benediktsdottir, K.5
Eyfjord, J.E.6
Jonsson, E.7
-
55
-
-
34347273049
-
Prostate cancer progression and survival in BRCA2 mutation carriers
-
DOI 10.1093/jnci/djm005
-
L. Tryggvadottir, L. Vidarsdottir, T. Thorgeirsson, J. G. Jonasson, E. J. Olafsdottir, G. H. Olafsdottir, T. Rafnar, S. Thorlacius, E. Jonsson, J. E. Eyfjord and H. Tulinius: Prostate cancer progression and survival in BRCA2 mutation carriers. J Natl Cancer Inst, 99(12), 929-35 (2007). (Pubitemid 47073499)
-
(2007)
Journal of the National Cancer Institute
, vol.99
, Issue.12
, pp. 929-935
-
-
Tryggvadottir, L.1
Vidarsdottir, L.2
Thorgeirsson, T.3
Jonasson, J.G.4
Olafsdottir, E.J.5
Olafsdottir, G.H.6
Rafnar, T.7
Thorlacius, S.8
Jonsson, E.9
Eyfjord, J.E.10
Tulinius, H.11
-
56
-
-
2942572799
-
A high proportion of founder BRCA1 mutations in Polish breast cancer families
-
DOI 10.1002/ijc.20162
-
B. Gorski, A. Jakubowska, T. Huzarski, T. Byrski, J. Gronwald, E. Grzybowska, A. Mackiewicz, M. Stawicka, M. Bebenek, D. Sorokin, L. Fiszer-Maliszewska, O. Haus, H. Janiszewska, S. Niepsuj, S. Gozdz, L. Zaremba, M. Posmyk, M. Pluzanska, E. Kilar, D. Czudowska, B. Wasko, R. Miturski, J. R. Kowalczyk, K. Urbanski, M. Szwiec, J. Koc, B. Debniak, A. Rozmiarek, T. Debniak, C. Cybulski, E. Kowalska, A. Toloczko-Grabarek, S. Zajaczek, J. Menkiszak, K. Medrek, B. Masojc, M. Mierzejewski, S. A. Narod and J. Lubinski: A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer, 110(5), 683-6 (2004). (Pubitemid 38746026)
-
(2004)
International Journal of Cancer
, vol.110
, Issue.5
, pp. 683-686
-
-
Gorski, B.1
Jakubowska, A.2
Huzarski, T.3
Byrski, T.4
Gronwald, J.5
Grzybowska, E.6
Mackiewicz, A.7
Stawicka, M.8
Bebenek, M.9
Sorokin, D.10
Fiszer-Maliszewska, L.11
Haus, O.12
Janiszewska, H.13
Niepsuj, S.14
Gozdz, S.15
Zaremba, L.16
Posmyk, M.17
Pluzanska, M.18
Kilar, E.19
Czudowska, D.20
Wasko, B.21
Miturski, R.22
Kowalczyk, J.R.23
Urbanski, K.24
Szwiec, M.25
Koc, J.26
Debniak, B.27
Rozmiarek, A.28
Debniak, T.29
Cybulski, C.30
Kowalska, E.31
Toloczko-Grabarek, A.32
Zajaczek, S.33
Menkiszak, J.34
Medrek, K.35
Masojc, B.36
Mierzejewski, M.37
Narod, S.A.38
Lubinski, J.39
more..
-
57
-
-
37349004046
-
BRCA1 mutations and prostate cancer in Poland
-
DOI 10.1097/CEJ.0b013e32809b4d20, PII 0000846920080200000010
-
C. Cybulski, B. Gorski, J. Gronwald, T. Huzarski, T. Byrski, T. Debniak, A. Jakubowska, D. Wokolorczyk, B. Gliniewicz, A. Sikorski, M. Stawicka, D. Godlewski, Z. Kwias, A. Antczak, K. Krajka, W. Lauer, M. Sosnowski, P. Sikorska-Radek, K. Bar, R. Klijer, Z. Romuald, B. Malkiewicz, A. Borkowski, T. Borkowski, M. Szwiec, M. Posmyk, S. A. Narod and J. Lubinski: BRCA1 mutations and prostate cancer in Poland. Eur J Cancer Prev, 17(1), 62-6 (2008). (Pubitemid 350307519)
-
(2008)
European Journal of Cancer Prevention
, vol.17
, Issue.1
, pp. 62-66
-
-
Cybulski, C.1
Gorski, B.2
Gronwald, J.3
Huzarski, T.4
Byrski, T.5
Debniak, T.6
Jakubowska, A.7
Wokolorczyk, D.8
Gliniewicz, B.9
Sikorski, A.10
Stawicka, M.11
Godlewski, D.12
Kwias, Z.13
Antczak, A.14
Krajka, K.15
Lauer, W.16
Sosnowski, M.17
Sikorska-Radek, P.18
Bar, K.19
Klijer, R.20
Romuald, Z.21
Malkiewicz, B.22
Borkowski, A.23
Borkowski, T.24
Szwiec, M.25
Posmyk, M.26
Narod, S.A.27
Lubinski, J.28
more..
-
58
-
-
17644444777
-
The r71g brca1 is a founder spanish mutation and leads to aberrant splicing of the transcript
-
A. Vega, B. Campos, B. Bressac-De-Paillerets, P. M. Bond, N. Janin, F. S. Douglas, M. Domenech, M. Baena, C. Pericay, C. Alonso, A. Carracedo, M. Baiget and O. Diez: The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript. Hum Mutat, 17(6), 520-1 (2001).
-
(2001)
Hum Mutat
, vol.17
, Issue.6
, pp. 520-521
-
-
Vega, A.1
Campos, B.2
Bressac-De-paillerets, B.3
Bond, P.M.4
Janin, N.5
Douglas, F.S.6
Domenech, M.7
Baena, M.8
Pericay, C.9
Alonso, C.10
Carracedo, A.11
Baiget, M.12
Diez, O.13
-
59
-
-
0036381338
-
Analysis of brca1 and brca2 in breast and breast/ovarian cancer families shows population substructure in the iberian peninsula
-
A. Vega, M. Torres, J. I. Martinez, C. Ruiz-Ponte, F. Barros and A. Carracedo: Analysis of BRCA1 and BRCA2 in breast and breast/ovarian cancer families shows population substructure in the Iberian peninsula. Ann Hum Genet, 66(Pt 1), 29-36 (2002).
-
(2002)
Ann Hum Genet
, vol.66
, Issue.PART 1
, pp. 29-36
-
-
Vega, A.1
Torres, M.2
Martinez, J.I.3
Ruiz-Ponte, C.4
Barros, F.5
Carracedo, A.6
-
60
-
-
68449087758
-
Haplotype and quantitative transcript analyses of portuguese breast/ovarian cancer families with the BRCA1 r71g founder mutation of galician origin
-
C. Santos, A. Peixoto, P. Rocha, A. Vega, M. J. Soares, N. Cerveira, S. Bizarro, M. Pinheiro, D. Pereira, H. Rodrigues, F. Castro, R. Henrique and M. R. Teixeira: Haplotype and quantitative transcript analyses of Portuguese breast/ovarian cancer families with the BRCA1 R71G founder mutation of Galician origin. Fam Cancer, 8(3), 203-8 (2009).
-
(2009)
Fam Cancer
, vol.8
, Issue.3
, pp. 203-208
-
-
Santos, C.1
Peixoto, A.2
Rocha, P.3
Vega, A.4
Soares, M.J.5
Cerveira, N.6
Bizarro, S.7
Pinheiro, M.8
Pereira, D.9
Rodrigues, H.10
Castro, F.11
Henrique, R.12
Teixeira, M.R.13
-
61
-
-
0036724556
-
Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan
-
DOI 10.1086/342506
-
A. Liede, I. A. Malik, Z. Aziz, L. Rios Pd Pde, E. Kwan and S. A. Narod: Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan. Am J Hum Genet, 71(3), 595-606 (2002). (Pubitemid 34970130)
-
(2002)
American Journal of Human Genetics
, vol.71
, Issue.3
, pp. 595-606
-
-
Liede, A.1
Malik, I.A.2
Aziz, Z.3
De Los Rios, P.4
Kwan, E.5
Narod, S.A.6
-
62
-
-
19144364122
-
Founding BRCA1 mutations in hereditary breast and ovarian cancer in Southern Sweden
-
O. Johannsson, E. A. Ostermeyer, S. Hakansson, L. S. Friedman, U. Johansson, G. Sellberg, K. Brondum-Nielsen, V. Sele, H. Olsson, M. C. King and A. Borg: Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. Am J Hum Genet, 58(3), 441-50 (1996). (Pubitemid 26062474)
-
(1996)
American Journal of Human Genetics
, vol.58
, Issue.3
, pp. 441-450
-
-
Johannsson, O.1
Ostermeyer, E.A.2
Hakansson, S.3
Friedman, L.S.4
Johansson, U.5
Sellberg, G.6
Brondum-Nielsen, K.7
Sele, V.8
Olsson, H.9
King, M.-C.10
Borg, A.11
-
63
-
-
45149114013
-
BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer
-
DOI 10.1080/02841860802004974, PII 791892967
-
M. Thomassen, T. V. Hansen, A. Borg, H. T. Lianee, F. Wikman, I. S. Pedersen, M. L. Bisgaard, F. C. Nielsen, T. A. Kruse and A. M. Gerdes: BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer. Acta Oncol, 47(4), 772-7 (2008). (Pubitemid 351878455)
-
(2008)
Acta Oncologica
, vol.47
, Issue.4
, pp. 772-777
-
-
Thomassen, M.1
Hansen, T.V.O.2
Borg, A.3
Theilmann Lianee, H.4
Wikman, F.5
Sokilde Pedersen, I.6
Luise Bisgaard, M.7
Nielsen, F.C.8
Kruse, T.A.9
Gerdes, A.-M.10
-
64
-
-
80053956117
-
Brca2 is a moderate penetrance gene contributing to young-onset prostate cancer: Implications for genetic testing in prostate cancer patients
-
Z. Kote-Jarai, D. Leongamornlert, E. Saunders, M. Tymrakiewicz, E. Castro, N. Mahmud, M. Guy, S. Edwards, L. O'Brien, E. Sawyer, A. Hall, R. Wilkinson, T. Dadaev, C. Goh, D. Easton, D. Goldgar and R. Eeles: BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients. Br J Cancer, 105(8), 1230-4 (2011).
-
(2011)
Br J Cancer
, vol.105
, Issue.8
, pp. 1230-1234
-
-
Kote-Jarai, Z.1
Leongamornlert, D.2
Saunders, E.3
Tymrakiewicz, M.4
Castro, E.5
Mahmud, N.6
Guy, M.7
Edwards, S.8
O'Brien, L.9
Sawyer, E.10
Hall, A.11
Wilkinson, R.12
Dadaev, T.13
Goh, C.14
Easton, D.15
Goldgar, D.16
Eeles, R.17
-
65
-
-
38549123031
-
Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
-
DOI 10.1038/sj.bjc.6604132, PII 6604132
-
A. Mitra, C. Fisher, C. S. Foster, C. Jameson, Y. Barbachanno, J. Bartlett, E. Bancroft, R. Doherty, Z. Kote- Jarai, S. Peock, D. Easton and R. Eeles: Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype. Br J Cancer, 98(2), 502-7 (2008). (Pubitemid 351161242)
-
(2008)
British Journal of Cancer
, vol.98
, Issue.2
, pp. 502-507
-
-
Mitra, A.1
Fisher, C.2
Foster, C.S.3
Jameson, C.4
Barbachanno, Y.5
Bartlett, J.6
Bancroft, E.7
Doherty, R.8
Kote-Jarai, Z.9
Peock, S.10
Easton, D.11
Eeles, R.12
-
66
-
-
0034662631
-
The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer
-
S. A. Gayther, K. A. de Foy, P. Harrington, P. Pharoah, W. D. Dunsmuir, S. M. Edwards, C. Gillett, A. Ardern-Jones, D. P. Dearnaley, D. F. Easton, D. Ford, R. J. Shearer, R. S. Kirby, A. L. Dowe, J. Kelly, M. R. Stratton, B. A. Ponder, D. Barnes and R. A. Eeles: The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators. Cancer Res, 60(16), 4513-8 (2000). (Pubitemid 32103633)
-
(2000)
Cancer Research
, vol.60
, Issue.16
, pp. 4513-4518
-
-
Gayther, S.A.1
De Foy, K.A.F.2
Harrington, P.3
Pharoah, P.4
Dunsmuir, W.D.5
Edwards, S.M.6
Gillett, C.7
Ardern-Jones, A.8
Dearnaley, D.P.9
Easton, D.F.10
Ford, D.11
Shearer, R.J.12
Kirby, R.S.13
Dowe, A.L.14
Kelly, J.15
Stratton, M.R.16
Ponder, B.A.J.17
Barnes, D.18
Eeles, R.A.19
-
67
-
-
0035150431
-
BRCA2 mutation in a family with hereditary prostate cancer
-
H. Gronberg, A. K. Ahman, M. Emanuelsson, A. Bergh, J. E. Damber and A. Borg: BRCA2 mutation in a family with hereditary prostate cancer. Genes Chromosomes Cancer, 30(3), 299-301 (2001). (Pubitemid 32126207)
-
(2001)
Genes Chromosomes and Cancer
, vol.30
, Issue.3
, pp. 299-301
-
-
Grnberg, H.1
Hman, A.K.2
Emanuelsson, M.3
Bergh, A.4
Damber, J.E.5
Borg, A.6
-
68
-
-
77951296146
-
A novel brca2 mutation that segregates with breast and prostate cancer in a spanish family
-
J. Salgado, J. M. Aramendia, C. Gutierrez, C. Gil, M. Robles and J. Garcia-Foncillas: A novel BRCA2 mutation that segregates with breast and prostate cancer in a Spanish family. Breast Cancer Res Treat, 121(1), 219-20 (2010).
-
(2010)
Breast Cancer Res Treat
, vol.121
, Issue.1
, pp. 219-220
-
-
Salgado, J.1
Aramendia, J.M.2
Gutierrez, C.3
Gil, C.4
Robles, M.5
Garcia-Foncillas, J.6
-
69
-
-
78650011793
-
Germline mutations of BRCA1 and BRCA2 genes in turkish breast, ovarian, and prostate cancer patients
-
E. Manguoglu, S. Guran, D. Yamac, T. Colak, M. Simsek, M. Baykara, M. Akaydin and G. Luleci: Germline mutations of BRCA1 and BRCA2 genes in Turkish breast, ovarian, and prostate cancer patients. Cancer Genet Cytogenet, 203(2), 230-7 (2010).
-
(2010)
Cancer Genet Cytogenet
, vol.203
, Issue.2
, pp. 230-237
-
-
Manguoglu, E.1
Guran, S.2
Yamac, D.3
Colak, T.4
Simsek, M.5
Baykara, M.6
Akaydin, M.7
Luleci, G.8
-
70
-
-
77956436462
-
Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
-
S. M. Edwards, D. G. Evans, Q. Hope, A. R. Norman, Y. Barbachano, S. Bullock, Z. Kote-Jarai, J. Meitz, A. Falconer, P. Osin, C. Fisher, M. Guy, S. G. Jhavar, A. L. Hall, L. T. O'Brien, B. N. Gehr-Swain, R. A. Wilkinson, M. S. Forrest, D. P. Dearnaley, A. T. Ardern-Jones, E. C. Page, D. F. Easton and R. A. Eeles: Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis. Br J Cancer, 103(6), 918-24 (2010).
-
(2010)
Br J Cancer
, vol.103
, Issue.6
, pp. 918-924
-
-
Edwards, S.M.1
Evans, D.G.2
Hope, Q.3
Norman, A.R.4
Barbachano, Y.5
Bullock, S.6
Kote-Jarai, Z.7
Meitz, J.8
Falconer, A.9
Osin, P.10
Fisher, C.11
Guy, M.12
Jhavar, S.G.13
Hall, A.L.14
O'brien, L.T.15
Gehr-Swain, B.N.16
Wilkinson, R.A.17
Forrest, M.S.18
Dearnaley, D.P.19
Ardern-Jones, A.T.20
Page, E.C.21
Easton, D.F.22
Eeles, R.A.23
more..
-
71
-
-
48249136563
-
Rapid progression of prostate cancer in men with a brca2 mutation
-
S. A. Narod, S. Neuhausen, G. Vichodez, S. Armel, H. T. Lynch, P. Ghadirian, S. Cummings, O. Olopade, D. Stoppa-Lyonnet, F. Couch, T. Wagner, E. Warner, W. D. Foulkes, H. Saal, J. Weitzel, A. Tulman, A. Poll, R. Nam, P. Sun, J. Danquah, S. Domchek, N. Tung, P. Ainsworth, D. Horsman, C. Kim-Sing, C. Maugard, A. Eisen, M. Daly, W. McKinnon, M. Wood, C. Isaacs, D. Gilchrist, B. Karlan, R. Nedelcu, W. Meschino, J. Garber, B. Pasini, S. Manoukian and C. Bellati: Rapid progression of prostate cancer in men with a BRCA2 mutation. Br J Cancer, 99(2), 371-4 (2008).
-
(2008)
Br J Cancer
, vol.99
, Issue.2
, pp. 371-374
-
-
Narod, S.A.1
Neuhausen, S.2
Vichodez, G.3
Armel, S.4
Lynch, H.T.5
Ghadirian, P.6
Cummings, S.7
Olopade, O.8
Stoppa-Lyonnet, D.9
Couch, F.10
Wagner, T.11
Warner, E.12
Foulkes, W.D.13
Saal, H.14
Weitzel, J.15
Tulman, A.16
Poll, A.17
Nam, R.18
Sun, P.19
Danquah, J.20
Domchek, S.21
Tung, N.22
Ainsworth, P.23
Horsman, D.24
Kim-Sing, C.25
Maugard, C.26
Eisen, A.27
Daly, M.28
McKinnon, W.29
Wood, M.30
Isaacs, C.31
Gilchrist, D.32
Karlan, B.33
Nedelcu, R.34
Meschino, W.35
Garber, J.36
Pasini, B.37
Manoukian, S.38
Bellati, C.39
more..
-
72
-
-
79960094457
-
Decreased prostate cancer-specific survival of men with brca2 mutations from multiple breast cancer families
-
Phila
-
H. Thorne, A. J. Willems, E. Niedermayr, I. M. Hoh, J. Li, D. Clouston, G. Mitchell, S. Fox, J. L. Hopper and D. Bolton: Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families. Cancer Prev Res (Phila), 4(7), 1002-10 (2011).
-
(2011)
Cancer Prev Res
, vol.4
, Issue.7
, pp. 1002-1010
-
-
Thorne, H.1
Willems, A.J.2
Niedermayr, E.3
Hoh, I.M.4
Li, J.5
Clouston, D.6
Mitchell, G.7
Fox, S.8
Hopper, J.L.9
Bolton, D.10
-
73
-
-
0034162984
-
BRCA1 and BRCA2 have a limited role in familial prostate cancer
-
C. S. Sinclair, R. Berry, D. Schaid, S. N. Thibodeau and F. J. Couch: BRCA1 and BRCA2 have a limited role in familial prostate cancer. Cancer Res, 60(5), 1371-5 (2000). (Pubitemid 30152009)
-
(2000)
Cancer Research
, vol.60
, Issue.5
, pp. 1371-1375
-
-
Sinclair, C.S.1
Berry, R.2
Schaid, D.3
Thibodeau, S.N.4
Couch, F.J.5
-
74
-
-
4644363085
-
Truncating BRCA1 mutations are uncommon in a cohort of hereditary prostate cancer families with evidence of linkage to 17q markers
-
DOI 10.1158/1078-0432.CCR-04-0554
-
K. A. Zuhlke, J. J. Madeoy, J. Beebe-Dimmer, K. A. White, A. Griffin, E. M. Lange, S. B. Gruber, E. A. Ostrander and K. A. Cooney: Truncating BRCA1 mutations are uncommon in a cohort of hereditary prostate cancer families with evidence of linkage to 17q markers. Clin Cancer Res, 10(18 Pt 1), 5975-80 (2004). (Pubitemid 39287501)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.I18
, pp. 5975-5980
-
-
Zuhlke, K.A.1
Madeoy, J.J.2
Beebe-Dimmer, J.3
White, K.A.4
Griffin, A.5
Lange, E.M.6
Gruber, S.B.7
Ostrander, E.A.8
Cooney, K.A.9
-
75
-
-
34447507853
-
Common variation in the BRCA1 gene and prostate cancer risk
-
DOI 10.1158/1055-9965.EPI-07-0137
-
J. A. Douglas, A. M. Levin, K. A. Zuhlke, A. M. Ray, G. R. Johnson, E. M. Lange, D. P. Wood and K. A. Cooney: Common variation in the BRCA1 gene and prostate cancer risk. Cancer Epidemiol Biomarkers Prev, 16(7), 1510-6 (2007). (Pubitemid 47076887)
-
(2007)
Cancer Epidemiology Biomarkers and Prevention
, vol.16
, Issue.7
, pp. 1510-1516
-
-
Douglas, J.A.1
Levin, A.M.2
Zuhlke, K.A.3
Ray, A.M.4
Johnson, G.R.5
Lange, E.M.6
Wood, D.P.7
Cooney, K.A.8
-
76
-
-
0345374575
-
Genome-wide scan for prostate cancer susceptibility genes using families from the university of michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near brca1
-
DOI 10.1002/pros.10307
-
E. M. Lange, E. M. Gillanders, C. C. Davis, W. M. Brown, J. K. Campbell, M. Jones, D. Gildea, E. Riedesel, J. Albertus, D. Freas-Lutz, C. Markey, V. Giri, J. B. Dimmer, J. E. Montie, J. M. Trent and K. A. Cooney: Genome-wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1. Prostate, 57(4), 326-34 (2003). (Pubitemid 37487078)
-
(2003)
Prostate
, vol.57
, Issue.4
, pp. 326-334
-
-
Lange, E.M.1
Gillanders, E.M.2
Davis, C.C.3
Brown, W.M.4
Campbell, J.K.5
Jones, M.6
Gildea, D.7
Riedesel, E.8
Albertus, J.9
Freas-Lutz, D.10
Markey, C.11
Giri, V.12
Dimmer, J.B.13
Montie, J.E.14
Trent, J.M.15
Cooney, K.A.16
-
77
-
-
0035154741
-
Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men
-
DOI 10.1016/S0090-4295(00)00873-6, PII S0090429500008736
-
K. A. Cooney, M. S. Strawderman, K. J. Wojno, K. M. Doerr, A. Taylor, K. H. Alcser, S. G. Heeringa, J. M. Taylor, J. T. Wei, J. E. Montie and D. Schottenfeld: Agespecific distribution of serum prostate-specific antigen in a community-based study of African-American men. Urology, 57(1), 91-6 (2001). (Pubitemid 32065826)
-
(2001)
Urology
, vol.57
, Issue.1
, pp. 91-96
-
-
Cooney, K.A.1
Strawderman, M.S.2
Wojno, K.J.3
Doerr, K.M.4
Taylor, A.5
Alcser, K.H.6
Heeringa, S.G.7
Taylor, J.M.G.8
Wei, J.T.9
Montie, J.E.10
Schottenfeld, D.11
-
78
-
-
0032507879
-
BRCA1 as a potential human prostate tumor suppressor: Modulation of proliferation, damage responses and expression of cell regulatory proteins
-
S. Fan, J. A. Wang, R. Q. Yuan, Y. X. Ma, Q. Meng, M. R. Erdos, L. C. Brody, I. D. Goldberg and E. M. Rosen: BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins. Oncogene, 16(23), 3069-82 (1998). (Pubitemid 28297729)
-
(1998)
Oncogene
, vol.16
, Issue.23
, pp. 3069-3082
-
-
Fan, S.1
Wang, J.-A.2
Yuan, R.-Q.3
Ma, Y.X.4
Meng, Q.5
Erdos, M.R.6
Brody, L.C.7
Goldberg, I.D.8
Rosen, E.M.9
-
79
-
-
34548484801
-
BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers
-
DOI 10.1038/sj.onc.1210420, PII 1210420
-
C. Yuli, N. Shao, R. Rao, P. Aysola, V. Reddy, G. Oprea-llies, L. Lee, J. Okoli, E. Partridge, E. S. Reddy and V. N. Rao: BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers. Oncogene, 26(41), 6031-7 (2007). (Pubitemid 47373802)
-
(2007)
Oncogene
, vol.26
, Issue.41
, pp. 6031-6037
-
-
Yuli, C.1
Shao, N.2
Rao, R.3
Aysola, P.4
Reddy, V.5
Oprea-Llies, G.6
Lee, L.7
Okoli, J.8
Partridge, E.9
Reddy, E.S.P.10
Rao, V.N.11
-
80
-
-
77954233490
-
BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood
-
N. Bednarz, E. Eltze, A. Semjonow, M. Rink, A. Andreas, L. Mulder, J. Hannemann, M. Fisch, K. Pantel, H. U. Weier, K. P. Bielawski and B. Brandt: BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood. Clin Cancer Res, 16(13), 3340-8 (2010).
-
(2010)
Clin Cancer Res
, vol.16
, Issue.13
, pp. 3340-3348
-
-
Bednarz, N.1
Eltze, E.2
Semjonow, A.3
Rink, M.4
Andreas, A.5
Mulder, L.6
Hannemann, J.7
Fisch, M.8
Pantel, K.9
Weier, H.U.10
Bielawski, K.P.11
Brandt, B.12
-
81
-
-
63449121864
-
Tumor suppressor brca1 is expressed in prostate cancer and controls insulin-like growth factor i receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner
-
H. Schayek, K. Haugk, S. Sun, L. D. True, S. R. Plymate and H. Werner: Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner. Clin Cancer Res, 15(5), 1558-65 (2009).
-
(2009)
Clin Cancer Res
, vol.15
, Issue.5
, pp. 1558-1565
-
-
Schayek, H.1
Haugk, K.2
Sun, S.3
True, L.D.4
Plymate, S.R.5
Werner, H.6
-
82
-
-
34548550432
-
Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis
-
DOI 10.1158/0008-5472.CAN-07-1515
-
K. K. Deeb, A. M. Michalowska, C. Y. Yoon, S. M. Krummey, M. J. Hoenerhoff, C. Kavanaugh, M. C. Li, F. J. Demayo, I. Linnoila, C. X. Deng, E. Y. Lee, D. Medina, J. H. Shih and J. E. Green: Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis. Cancer Res, 67(17), 8065-80 (2007). (Pubitemid 47395141)
-
(2007)
Cancer Research
, vol.67
, Issue.17
, pp. 8065-8080
-
-
Deeb, K.K.1
Michalowska, A.M.2
Yoon, C.-Y.3
Krummey, S.M.4
Hoenerhoff, M.J.5
Kavanaugh, C.6
Li, M.-C.7
Demayo, F.J.8
Linnoila, I.9
Deng, C.-X.10
Lee, E.Y.-H.P.11
Medina, D.12
Shih, J.H.13
Green, J.E.14
-
83
-
-
79959245402
-
Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer
-
A. A. Arbini, M. Greco, J. L. Yao, P. Bourne, E. Marra, J. T. Hsieh, P. A. di Sant'agnese and L. Moro: Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer. Am J Pathol, 178(5), 2367-76 (2011).
-
(2011)
Am J Pathol
, vol.178
, Issue.5
, pp. 2367-2376
-
-
Arbini, A.A.1
Greco, M.2
Yao, J.L.3
Bourne, P.4
Marra, E.5
Hsieh, J.T.6
Di Sant'agnese, P.A.7
Moro, L.8
-
84
-
-
0033660593
-
Estrogen receptormediated processes in normal and cancer cells
-
R. B. Dickson and G. M. Stancel: Estrogen receptormediated processes in normal and cancer cells. J Natl Cancer Inst Monogr(27), 135-45 (2000).
-
(2000)
J Natl Cancer Inst Monogr
, Issue.27
, pp. 135-145
-
-
Dickson, R.B.1
Stancel, G.M.2
-
85
-
-
0033591295
-
BRCA1 inhibition of estrogen receptor signaling in transfected cells
-
DOI 10.1126/science.284.5418.1354
-
S. Fan, J. Wang, R. Yuan, Y. Ma, Q. Meng, M. R. Erdos, R. G. Pestell, F. Yuan, K. J. Auborn, I. D. Goldberg and E. M. Rosen: BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science, 284(5418), 1354-6 (1999). (Pubitemid 29289660)
-
(1999)
Science
, vol.284
, Issue.5418
, pp. 1354-1356
-
-
Fan, S.1
Wang, J.-A.2
Yuan, R.3
Ma, Y.4
Meng, Q.5
Erdos, M.R.6
Pestell, R.G.7
Yuan, F.8
Auborn, K.J.9
Goldberg, I.D.10
Rosen, E.M.11
-
86
-
-
0036755404
-
Androgen receptor as a target in androgenindependent prostate cancer
-
discussion 138-9
-
S. P. Balk: Androgen receptor as a target in androgenindependent prostate cancer. Urology, 60(3 Suppl 1), 132- 8; discussion 138-9 (2002).
-
(2002)
Urology
, vol.60
, Issue.3 SUPPL. 1
, pp. 132-138
-
-
Balk, S.P.1
-
87
-
-
0034327357
-
Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor
-
J. J. Park, R. A. Irvine, G. Buchanan, S. S. Koh, J. M. Park, W. D. Tilley, M. R. Stallcup, M. F. Press and G. A. Coetzee: Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor. Cancer Res, 60(21), 5946-9 (2000).
-
(2000)
Cancer Res
, vol.60
, Issue.21
, pp. 5946-5949
-
-
Park, J.J.1
Irvine, R.A.2
Buchanan, G.3
Koh, S.S.4
Park, J.M.5
Tilley, W.D.6
Stallcup, M.R.7
Press, M.F.8
Coetzee, G.A.9
-
88
-
-
0034633661
-
Increase of androgeninduced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells
-
S. Yeh, Y. C. Hu, M. Rahman, H. K. Lin, C. L. Hsu, H. J. Ting, H. Y. Kang and C. Chang: Increase of androgeninduced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells. Proc Natl Acad Sci U S A, 97(21), 11256-61 (2000).
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, Issue.21
, pp. 11256-11261
-
-
Yeh, S.1
Hu, Y.C.2
Rahman, M.3
Lin, H.K.4
Hsu, C.L.5
Ting, H.J.6
Kang, H.Y.7
Chang, C.8
-
89
-
-
0141895067
-
BRCA1 in hormone-responsive cancers
-
DOI 10.1016/j.tem.2003.08.001
-
E. M. Rosen, S. Fan, R. G. Pestell and I. D. Goldberg: BRCA1 in hormone-responsive cancers. Trends Endocrinol Metab, 14(8), 378-85 (2003). (Pubitemid 37236959)
-
(2003)
Trends in Endocrinology and Metabolism
, vol.14
, Issue.8
, pp. 378-385
-
-
Rosen, E.M.1
Fan, S.2
Pestell, R.G.3
Goldberg, I.D.4
-
90
-
-
0035910507
-
Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells
-
DOI 10.1016/S0014-5793(00)02430-3, PII S0014579300024303
-
B. Gao, X. Shen, G. Kunos, Q. Meng, I. D. Goldberg, E. M. Rosen and S. Fan: Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells. FEBS Lett, 488(3), 179-84 (2001). (Pubitemid 32103593)
-
(2001)
FEBS Letters
, vol.488
, Issue.3
, pp. 179-184
-
-
Gao, B.1
Shen, X.2
Kunos, G.3
Meng, Q.4
Goldberg, I.D.5
Rosen, E.M.6
Fan, S.7
-
91
-
-
76549122939
-
Transcriptional autoregulation by brca1
-
A. De Siervi, P. De Luca, J. S. Byun, L. J. Di, T. Fufa, C. M. Haggerty, E. Vazquez, C. Moiola, D. L. Longo and K. Gardner: Transcriptional autoregulation by BRCA1. Cancer Res, 70(2), 532-42 (2010).
-
(2010)
Cancer Res
, vol.70
, Issue.2
, pp. 532-542
-
-
De Siervi, A.1
De Luca, P.2
Byun, J.S.3
Di, L.J.4
Fufa, T.5
Haggerty, C.M.6
Vazquez, E.7
Moiola, C.8
Longo, D.L.9
Gardner, K.10
-
92
-
-
84864106481
-
Dynamic coregulatory complex containing BRCA1, e2f1 and ctip controls ATM transcription
-
C. Moiola, P. De Luca, J. Cotignola, K. Gardner, E. Vazquez and A. De Siervi: Dynamic coregulatory complex containing BRCA1, E2F1 and CtIP controls ATM transcription. Cell Physiol Biochem, 30(3), 596-608 (2012).
-
(2012)
Cell Physiol Biochem
, vol.30
, Issue.3
, pp. 596-608
-
-
Moiola, C.1
De Luca, P.2
Cotignola, J.3
Gardner, K.4
Vazquez, E.5
De Siervi, A.6
-
93
-
-
66149158200
-
PKCalpha activation downregulates atm and radio-sensitizes androgen-sensitive human prostate cancer cells in vitro and in vivo
-
J. P. Truman, S. A. Rotenberg, J. H. Kang, G. Lerman, Z. Fuks, R. Kolesnick, V. E. Marquez and A. Haimovitz- Friedman: PKCalpha activation downregulates ATM and radio-sensitizes androgen-sensitive human prostate cancer cells in vitro and in vivo. Cancer Biol Ther, 8(1), 54-63 (2009).
-
(2009)
Cancer Biol Ther
, vol.8
, Issue.1
, pp. 54-63
-
-
Truman, J.P.1
Rotenberg, S.A.2
Kang, J.H.3
Lerman, G.4
Fuks, Z.5
Kolesnick, R.6
Marquez, V.E.7
Friedman A.H.-8
-
94
-
-
0029826841
-
Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin- like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium
-
DOI 10.1210/jc.81.10.3774
-
M. K. Tennant, J. B. Thrasher, P. A. Twomey, R. H. Drivdahl, R. S. Birnbaum and S. R. Plymate: Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium. J Clin Endocrinol Metab, 81(10), 3774-82 (1996). (Pubitemid 26339953)
-
(1996)
Journal of Clinical Endocrinology and Metabolism
, vol.81
, Issue.10
, pp. 3774-3782
-
-
Tennant, M.K.1
Thrasher, J.B.2
Twomey, P.A.3
Drivdahl, R.H.4
Birnbaum, R.S.5
Plymate, S.R.6
-
95
-
-
33748927940
-
Interaction of IGF signaling and the androgen receptor in prostate cancer progression
-
DOI 10.1002/jcb.20929
-
J. D. Wu, K. Haugk, L. Woodke, P. Nelson, I. Coleman and S. R. Plymate: Interaction of IGF signaling and the androgen receptor in prostate cancer progression. J Cell Biochem, 99(2), 392-401 (2006). (Pubitemid 44435557)
-
(2006)
Journal of Cellular Biochemistry
, vol.99
, Issue.2
, pp. 392-401
-
-
Wu, J.D.1
Haugk, K.2
Woodke, L.3
Nelson, P.4
Coleman, I.5
Plymate, S.R.6
-
96
-
-
64249111139
-
Circulating insulin-like growth factor peptides and prostate cancer risk: A systematic review and meta-analysis
-
M. A. Rowlands, D. Gunnell, R. Harris, L. J. Vatten, J. M. Holly and R. M. Martin: Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer, 124(10), 2416-29 (2009).
-
(2009)
Int J Cancer
, vol.124
, Issue.10
, pp. 2416-2429
-
-
Rowlands, M.A.1
Gunnell, D.2
Harris, R.3
Vatten, L.J.4
Holly, J.M.5
Martin, R.M.6
-
97
-
-
0032559272
-
Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
-
DOI 10.1126/science.279.5350.563
-
J. M. Chan, M. J. Stampfer, E. Giovannucci, P. H. Gann, J. Ma, P. Wilkinson, C. H. Hennekens and M. Pollak: Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science, 279(5350), 563-6 (1998). (Pubitemid 28067285)
-
(1998)
Science
, vol.279
, Issue.5350
, pp. 563-566
-
-
Chan, J.M.1
Stampfer, M.J.2
Giovannucci, E.3
Gann, P.H.4
Ma, J.5
Wilkinson, P.6
Hennekens, C.H.7
Pollak, M.8
-
98
-
-
0035881876
-
In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR)
-
T. Nickerson, F. Chang, D. Lorimer, S. P. Smeekens, C. L. Sawyers and M. Pollak: In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR). Cancer Res, 61(16), 6276-80 (2001). (Pubitemid 32762567)
-
(2001)
Cancer Research
, vol.61
, Issue.16
, pp. 6276-6280
-
-
Nickerson, T.1
Chang, F.2
Lorimer, D.3
Smeekens, S.P.4
Sawyers, C.L.5
Pollak, M.6
-
99
-
-
0034033970
-
BRCA1 suppresses insulin-like growth factor-I receptor promoter activity: Potential interaction between BRCA1 and Sp1
-
DOI 10.1006/mgme.1999.2958
-
S. B. Maor, S. Abramovitch, M. R. Erdos, L. C. Brody and H. Werner: BRCA1 suppresses insulin-like growth factor-I receptor promoter activity: potential interaction between BRCA1 and Sp1. Mol Genet Metab, 69(2), 130-6 (2000). (Pubitemid 30180697)
-
(2000)
Molecular Genetics and Metabolism
, vol.69
, Issue.2
, pp. 130-136
-
-
Maor, S.B.1
Abramovitch, S.2
Erdos, M.R.3
Brody, L.C.4
Werner, H.5
-
100
-
-
0036847690
-
Elevated Skp2 protein expression in human prostate cancer: Association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival
-
G. Yang, G. Ayala, A. De Marzo, W. Tian, A. Frolov, T. M. Wheeler, T. C. Thompson and J. W. Harper: Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival. Clin Cancer Res, 8(11), 3419-26 (2002). (Pubitemid 35340716)
-
(2002)
Clinical Cancer Research
, vol.8
, Issue.11
, pp. 3419-3426
-
-
Yang, G.1
Ayala, G.2
De Marzo, A.3
Tian, W.4
Frolov, A.5
Wheeler, T.M.6
Thompson, T.C.7
Harper, J.W.8
-
101
-
-
12444339727
-
Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients
-
M. Drobnjak, J. Melamed, S. Taneja, K. Melzer, R. Wieczorek, B. Levinson, A. Zeleniuch-Jacquotte, D. Polsky, J. Ferrara, R. Perez-Soler, C. Cordon-Cardo, M. Pagano and I. Osman: Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients. Clin Cancer Res, 9(7), 2613-9 (2003). (Pubitemid 36842104)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.7
, pp. 2613-2619
-
-
Drobnjak, M.1
Melamed, J.2
Taneja, S.3
Melzer, K.4
Wieczorek, R.5
Levinson, B.6
Zeleniuch-Jacquotte, A.7
Polsky, D.8
Ferrara, J.9
Perez-Soler, R.10
Cordon-Cardo, C.11
Pagano, M.12
Osman, I.13
-
102
-
-
79955745145
-
The impact of skp2 overexpression on recurrence-free survival following radical prostatectomy
-
P. L. Nguyen, D. I. Lin, J. Lei, M. Fiorentino, E. Mueller, M. H. Weinstein, M. Pagano and M. Loda: The impact of Skp2 overexpression on recurrence-free survival following radical prostatectomy. Urol Oncol, 29(3), 302-8 (2011).
-
(2011)
Urol Oncol
, vol.29
, Issue.3
, pp. 302-308
-
-
Nguyen, P.L.1
Lin, D.I.2
Lei, J.3
Fiorentino, M.4
Mueller, E.5
Weinstein, M.H.6
Pagano, M.7
Loda, M.8
-
103
-
-
33746837658
-
Up-regulation of Skp2 after prostate cancer cell adhesion to basement membranes results in BRCA2 degradation and cell proliferation
-
DOI 10.1074/jbc.M604636200
-
L. Moro, A. A. Arbini, E. Marra and M. Greco: Upregulation of Skp2 after prostate cancer cell adhesion to basement membranes results in BRCA2 degradation and cell proliferation. J Biol Chem, 281(31), 22100-7 (2006). (Pubitemid 44181914)
-
(2006)
Journal of Biological Chemistry
, vol.281
, Issue.31
, pp. 22100-22107
-
-
Moro, L.1
Arbini, A.A.2
Marra, E.3
Greco, M.4
-
104
-
-
4344717012
-
BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage
-
DOI 10.1128/MCB.24.17.7444-7455.2004
-
A. R. Schoenfeld, S. Apgar, G. Dolios, R. Wang and S. A. Aaronson: BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage. Mol Cell Biol, 24(17), 7444-55 (2004). (Pubitemid 39121473)
-
(2004)
Molecular and Cellular Biology
, vol.24
, Issue.17
, pp. 7444-7455
-
-
Schoenfeld, A.R.1
Apgar, S.2
Dolios, G.3
Wang, R.4
Aaronson, S.A.5
-
105
-
-
0032126029
-
Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells
-
D. W. Abbott, M. L. Freeman and J. T. Holt: Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells. J Natl Cancer Inst, 90(13), 978-85 (1998). (Pubitemid 28340438)
-
(1998)
Journal of the National Cancer Institute
, vol.90
, Issue.13
, pp. 978-985
-
-
Abbott, D.W.1
Freeman, M.L.2
Holt, J.T.3
-
106
-
-
0020601626
-
Loss of basement membrane components by invasive tumors but not by their benign counterparts
-
S. H. Barsky, G. P. Siegal, F. Jannotta and L. A. Liotta: Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest, 49(2), 140-7 (1983). (Pubitemid 13039938)
-
(1983)
Laboratory Investigation
, vol.49
, Issue.2
, pp. 140-147
-
-
Barsky, S.H.1
Siegal, G.P.2
Jannotta, F.3
Liotta, L.A.4
-
107
-
-
5044238876
-
Integrin signalling during tumour progression
-
DOI 10.1038/nrm1490
-
W. Guo and F. G. Giancotti: Integrin signalling during tumour progression. Nat Rev Mol Cell Biol, 5(10), 816-26 (2004). (Pubitemid 39336275)
-
(2004)
Nature Reviews Molecular Cell Biology
, vol.5
, Issue.10
, pp. 816-826
-
-
Guo, W.1
Giancotti, F.G.2
-
108
-
-
0030033379
-
Bone cell matrix promotes the adhesion of human prostatic carcinoma cells via the 1 integrin
-
DOI 10.1007/BF00157682
-
P. J. Kostenuik, O. Sanchez-Sweatman, F. W. Orr and G. Singh: Bone cell matrix promotes the adhesion of human prostatic carcinoma cells via the alpha 2 beta 1 integrin. Clin Exp Metastasis, 14(1), 19-26 (1996). (Pubitemid 26008958)
-
(1996)
Clinical and Experimental Metastasis
, vol.14
, Issue.1
, pp. 19-26
-
-
Kostenuik, P.J.1
Sanchez-Sweatman, O.2
William Orr, F.3
Singh, G.4
-
109
-
-
0025301851
-
The cellular basis of site-specific tumor metastasis
-
B. R. Zetter: The cellular basis of site-specific tumor metastasis. N Engl J Med, 322(9), 605-12 (1990). (Pubitemid 20190796)
-
(1990)
New England Journal of Medicine
, vol.322
, Issue.9
, pp. 605-612
-
-
Zetter, B.R.1
-
110
-
-
20444490365
-
Down-regulation of BRCA2 expression by collagen type I promotes prostate cancer cell proliferation
-
DOI 10.1074/jbc.M414091200
-
L. Moro, A. A. Arbini, E. Marra and M. Greco: Down-regulation of BRCA2 expression by collagen type I promotes prostate cancer cell proliferation. J Biol Chem, 280(23), 22482-91 (2005). (Pubitemid 40827904)
-
(2005)
Journal of Biological Chemistry
, vol.280
, Issue.23
, pp. 22482-22491
-
-
Moro, L.1
Arbini, A.A.2
Marra, E.3
Greco, M.4
-
111
-
-
36048936602
-
Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2
-
L. Moro, A. A. Arbini, E. Marra and M. Greco: Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2. Int J Oncol, 30(1), 217-24 (2007).
-
(2007)
Int J Oncol
, vol.30
, Issue.1
, pp. 217-224
-
-
Moro, L.1
Arbini, A.A.2
Marra, E.3
Greco, M.4
-
112
-
-
38949084511
-
Loss of BRCA2 promotes prostate cancer cell invasion through up-regulation of matrix metalloproteinase-9
-
DOI 10.1111/j.1349-7006.2007.00719.x
-
L. Moro, A. A. Arbini, J. L. Yao, P. A. di Sant'Agnese, E. Marra and M. Greco: Loss of BRCA2 promotes prostate cancer cell invasion through upregulation of matrix metalloproteinase-9. Cancer Sci, 99(3), 553-63 (2008). (Pubitemid 351228573)
-
(2008)
Cancer Science
, vol.29
, Issue.3
, pp. 553-563
-
-
Moro, L.1
Arbini, A.A.2
Yao, J.L.3
Di Sant'Agnese, P.A.4
Marra, E.5
Greco, M.6
-
113
-
-
0033564523
-
Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells
-
DOI 10.1002/(SICI)1097-0045(19990615)40:1<37::AID-PROS5>3.0.CO;2-P
-
R. Yuan, S. Fan, J. A. Wang, Q. Meng, Y. Ma, D. Schreiber, I. D. Goldberg and E. M. Rosen: Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells. Prostate, 40(1), 37-49 (1999). (Pubitemid 29244493)
-
(1999)
Prostate
, vol.40
, Issue.1
, pp. 37-49
-
-
Yuan, R.1
Fan, S.2
Wang, J.-A.3
Meng, Q.4
Ma, Y.5
Schreiber, D.6
Goldberg, I.D.7
Rosen, E.M.8
-
114
-
-
0034687341
-
The anti-proliferative effects of 1alpha, 25(OH)2d3 on breast and prostate cancer cells are associated with induction of brca1 gene expression
-
M. J. Campbell, A. F. Gombart, S. H. Kwok, S. Park and H. P. Koeffler: The anti-proliferative effects of 1alpha, 25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression. Oncogene, 19(44), 5091-7 (2000).
-
(2000)
Oncogene
, vol.19
, Issue.44
, pp. 5091-5097
-
-
Campbell, M.J.1
Gombart, A.F.2
Kwok, S.H.3
Park, S.4
Koeffler, H.P.5
-
115
-
-
32544442522
-
BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells
-
DOI 10.1038/sj.bjc.6602935, PII 6602935
-
S. Fan, Q. Meng, K. Auborn, T. Carter and E. M. Rosen: BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer, 94(3), 407-26 (2006) doi:10.1038/sj.bjc.6602935. (Pubitemid 43237565)
-
(2006)
British Journal of Cancer
, vol.94
, Issue.3
, pp. 407-426
-
-
Fan, S.1
Meng, Q.2
Auborn, K.3
Carter, T.4
Rosen, E.M.5
-
116
-
-
1442307845
-
Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: A review of the literature
-
DOI 10.1200/JCO.2004.05.055
-
A. Liede, B. Y. Karlan and S. A. Narod: Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol, 22(4), 735-42 (2004). (Pubitemid 41095079)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.4
, pp. 735-742
-
-
Liede, A.1
Karlan, B.Y.2
Narod, S.A.3
-
117
-
-
80051813565
-
A risk prediction algorithm based on family history and common genetic variants: Application to prostate cancer with potential clinical impact
-
R. J. Macinnis, A. C. Antoniou, R. A. Eeles, G. Severi, A. A. Al Olama, L. McGuffog, Z. Kote-Jarai, M. Guy, L. T. O'Brien, A. L. Hall, R. A. Wilkinson, E. Sawyer, A. T. Ardern-Jones, D. P. Dearnaley, A. Horwich, V. S. Khoo, C. C. Parker, R. A. Huddart, N. Van As, M. R. McCredie, D. R. English, G. G. Giles, J. L. Hopper and D. F. Easton: A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact. Genet Epidemiol, 35(6), 549-56 (2011).
-
(2011)
Genet Epidemiol
, vol.35
, Issue.6
, pp. 549-556
-
-
MacInnis, R.J.1
Antoniou, A.C.2
Eeles, R.A.3
Severi, G.4
Olama, A.A.A.5
McGuffog6
-
118
-
-
33847340612
-
Germline mutations in the BRCA2 gene and susceptibility to hereditary prostate cancer
-
DOI 10.1158/1078-0432.CCR-06-2164
-
I. Agalliu, E. M. Kwon, D. Zadory, L. McIntosh, J. Thompson, J. L. Stanford and E. A. Ostrander: Germline mutations in the BRCA2 gene and susceptibility to hereditary prostate cancer. Clin Cancer Res, 13(3), 839-43 (2007). (Pubitemid 46340357)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.3
, pp. 839-843
-
-
Agalliu, I.1
Kwon, E.M.2
Zadory, D.3
McIntosh, L.4
Thompson, J.5
Stanford, J.L.6
Ostrander, E.A.7
-
119
-
-
0142186730
-
BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland
-
T. Ikonen, M. P. Matikainen, K. Syrjakoski, N. Mononen, P. A. Koivisto, A. Rokman, E. H. Seppala, O. P. Kallioniemi, T. L. Tammela and J. Schleutker: BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland. J Med Genet, 40(8), e98 (2003).
-
(2003)
J Med Genet
, vol.40
, Issue.8
-
-
Ikonen, T.1
Matikainen, M.P.2
Syrjakoski, K.3
Mononen, N.4
Koivisto, P.A.5
Rokman, A.6
Seppala, E.H.7
Kallioniemi, O.P.8
Tammela, T.L.9
Schleutker, J.10
-
120
-
-
2542496143
-
Founder mutations in BRCA1/2 are not frequent in canadian ashkenazi jewish men with prostate cancer
-
N. Hamel, K. Kotar and W. D. Foulkes: Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer. BMC Med Genet, 4, 7 (2003).
-
(2003)
BMC Med Genet
, vol.4
, pp. 7
-
-
Hamel, N.1
Kotar, K.2
Foulkes, W.D.3
-
121
-
-
0033939978
-
Founder mutations in the BRCA1 gene polish families with breast-ovarian cancer
-
DOI 10.1086/302922
-
B. Gorski, T. Byrski, T. Huzarski, A. Jakubowska, J. Menkiszak, J. Gronwald, A. Pluzanska, M. Bebenek, L. Fischer-Maliszewska, E. Grzybowska, S. A. Narod and J. Lubinski: Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am J Hum Genet, 66(6), 1963-8 (2000). (Pubitemid 30480103)
-
(2000)
American Journal of Human Genetics
, vol.66
, Issue.6
, pp. 1963-1968
-
-
Gorski, B.1
Byrski, T.2
Huzarski, T.3
Jakubowska, A.4
Menkiszak, J.5
Gronwald, J.6
Pluzanska, A.7
Bebenek, M.8
Fischer-Maliszewska, L.9
Grzybowska, E.10
Narod, S.A.11
Lubinski, J.12
-
122
-
-
13344269668
-
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds
-
DOI 10.1038/ng0396-333
-
S. V. Tavtigian, J. Simard, J. Rommens, F. Couch, D. ShattuckEidens, S. Neuhausen, S. Merajver, S. Thorlacius, K. Offit, D. StoppaLyonnet, C. Belanger, R. Bell, S. Berry, R. Bogden, Q. Chen, T. Davis, M. Dumont, C. Frye, T. Hattier, S. Jammulapati, T. Janecki, P. Jiang, R. Kehrer, J. F. Leblanc, J. T. Mitchell, J. McArthurMorrison, K. Nguyen, Y. Peng, C. Samson, M. Schroeder, S. C. Snyder, L. Steele, M. Stringfellow, C. Stroup, B. Swedlund, J. Swensen, D. Teng, A. Thomas, T. Tran, T. Tran, M. Tranchant, J. WeaverFeldhaus, A. K. C. Wong, H. Shizuya, J. E. Eyfjord, L. CannonAlbright, F. Labrie, M. H. Skolnick, B. Weber, A. Kamb and D. E. Goldgar: The complete BRCA2 gene and mutations in chromosome 13qlinked kindreds. Nat Genet, 12(3), 333-337 (1996). (Pubitemid 26080098)
-
(1996)
Nature Genetics
, vol.12
, Issue.3
, pp. 333-337
-
-
Tavtigian, S.V.1
Simard, J.2
Rommens, J.3
Couch, F.4
Shattuck-Eidens, D.5
Neuhausen, S.6
Merajver, S.7
Thorlacius, S.8
Offit, K.9
Stoppa-Lyonnet, D.10
Belanger, C.11
Bell, R.12
Berry, S.13
Bogden, R.14
Chen, Q.15
Davis, T.16
Dumont, M.17
Frye, C.18
Hattier, T.19
Jammulapati, S.20
Janecki, T.21
Jiang, P.22
Kehrer, R.23
Leblanc, J.-F.24
Mitchell, J.T.25
McArthur-Morrison, J.26
Nguyen, K.27
Peng, Y.28
Samson, C.29
Schroeder, M.30
Snyder, S.C.31
Steele, L.32
Stringfellow, M.33
Stroup, C.34
Swedlund, B.35
Swensen, J.36
Teng, D.37
Thomas, A.38
Tran, T.39
Tran, T.40
Tranchant, M.41
Weaver-Feldhaus, J.42
Wong, A.K.C.43
Shizuya, H.44
Eyfjord, J.E.45
Cannon-Albright, L.46
Labrie, F.47
Skolnick, M.H.48
Weber, B.49
Kamb, A.50
Goldgar, D.E.51
more..
|